Top Biotechnology companies in Denmark by EBIT
Denmark
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 838.39 M
|
Dec. 31, 2023 | USD 216.88 | 1.28% |
|
Denmark |
|
| 2 |
USD 604.22 M
|
Dec. 31, 2023 | USD 54.16 | -1.39% |
|
Denmark |
|
| 3 |
USD 457.38 M
|
Dec. 31, 2023 | USD 5.46 | 0.56% |
|
Denmark |
|
| 4 |
USD 221.73 M
|
Dec. 31, 2023 | USD 26.62 | -0.36% |
|
Denmark |
|
| 5 |
USD 25.45 M
|
June 30, 2024 | USD 70.50 | 0.61% |
|
Denmark |
|
| 6 |
USD -4.00 K
|
Dec. 31, 2023 | USD 0.64 | 1.38% |
|
Denmark |
|
| 7 |
USD -1.71 M
|
Dec. 31, 2023 | USD 0.63 | -3.68% |
|
Denmark |
|
| 8 |
USD -1.85 M
|
Dec. 31, 2023 | USD 1.93 | -6.19% |
|
Denmark |
|
| 9 |
USD -5.63 M
|
Dec. 31, 2023 | USD 91.43 | -1.85% |
|
Denmark |
|
| 10 |
USD -6.50 M
|
Dec. 31, 2023 | USD 3.98 | 0.01% |
|
Denmark |
|
| 11 |
USD -8.96 M
|
Dec. 31, 2023 | USD 0.20 | -2.77% |
|
Denmark |
|
| 12 |
USD -9.05 M
|
Dec. 31, 2023 | USD 0.57 | 1.47% |
|
Denmark |
|
| 13 |
USD -9.82 M
|
Dec. 31, 2023 | USD 2.17 | 5.88% |
|
Denmark |
|
| 14 |
USD -100.16 M
|
Dec. 31, 2023 | USD 95.84 | 0.08% |
|
Denmark |
|
| 15 |
USD -474.70 M
|
Dec. 31, 2023 | USD 131.57 | -1.84% |
|
Denmark |
Frequently Asked Questions
-
Which Biotechnology company in Denmark has the highest EBIT ?
The Biotechnology company in Denmark with the highest EBIT is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 838.39 M.
-
Which Biotechnology company in Denmark has the lowest EBIT ?
The Biotechnology company in Denmark with the lowest EBIT is Ascendis Pharma A/S (NasdaqGS: ASND) at USD -474.70 M.
-
What are the top 10 Biotechnology companies in Denmark by EBIT ?
The top 10 Biotechnology companies in Denmark by EBIT are Genmab A/S, Novozymes A/S, H. Lundbeck A/S, Bavarian Nordic A/S, ChemoMetec A/S, Initiator Pharma A/S, BactiQuant A/S, ViroGates A/S, Gubra A/S and FluoGuide A/S.
-
What are the bottom 10 Biotechnology companies in Denmark by EBIT ?
The bottom 10 Biotechnology companies in Denmark by EBIT are Ascendis Pharma A/S, Zealand Pharma A/S, ExpreS2ion Biotech Holding AB (publ), Saniona AB (publ), BioPorto A/S, FluoGuide A/S, Gubra A/S, ViroGates A/S, BactiQuant A/S and Initiator Pharma A/S.